Inhibition of autophagy, either through 3-methyladenine treatment or knockdown of Beclin-1 or Atg12, significantly reduces the ability of human embryonic kidney cells (HEK293T) and malignant melanoma cells to present model antigen OVA or endogenous tumor antigens (229). This evidence concerns the gene BECN1 and neoplasm.